Related Experiment Video
Updated: Jun 21, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Using ontogeny information to build predictive models for drug elimination.
Jane Alcorn1, Patrick J McNamara
1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5C9. jane.alcorn@usask.ca
Drug Discovery Today
|June 14, 2008
Summary
Understanding drug elimination in children is crucial for safe dosing. Predictive models using ontogeny data can help design paediatric drug regimens and assess risks when specific data is lacking.
Area of Science:
- Pharmacology and Toxicology
- Paediatric Drug Development
Background:
- Incomplete understanding of developmental maturation of drug elimination mechanisms challenges paediatric dosage regimen design and toxicological risk assessment.
- Dynamic and variable maturation limits acquiring pharmacokinetic data in all paediatric populations.
Purpose of the Study:
- To review principal approaches for estimating paediatric systemic clearance in the absence of comprehensive age-group-specific data.
- To highlight the promise of predictive models using human ontogeny data for paediatric drug dosage and risk assessment.
Main Methods:
- Review of population pharmacokinetic models.
- Application of allometric scaling principles.
- Utilization of physiologically based clearance scaling models.
Main Results:
- Identified key modelling approaches for estimating paediatric systemic clearance.
- Demonstrated the potential of predictive models to overcome data limitations.
Conclusions:
- Population pharmacokinetic, allometric scaling, and physiologically based clearance scaling models are principal methods for estimating paediatric systemic clearance.
- Predictive models utilizing ontogeny data offer a promising solution for paediatric dosage regimen design and risk assessment.
Related Concept Videos
01:06Drug Elimination: The Concept of Clearance
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
01:17Kinetics of Drug Elimination
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.